123 related articles for article (PubMed ID: 29369179)
1. Targeted next-generation sequencing of malignant peripheral nerve sheath tumor of the pterygopalatine fossa with intracranial metastatic recurrence.
Bao X; Kong X; Yang C; Wu H; Ma W; Wang R
Medicine (Baltimore); 2018 Jan; 97(4):e9636. PubMed ID: 29369179
[TBL] [Abstract][Full Text] [Related]
2. Malignant peripheral nerve sheath tumor of intracranial nerve: a case series review.
Ziadi A; Saliba I
Auris Nasus Larynx; 2010 Oct; 37(5):539-45. PubMed ID: 20399579
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in pterygopalatine and infratemporal fossa malignant tumours: A single institution experience.
He Y; Yang H; Sun J; Zhang C; Zhu H; Liu Z
J Craniomaxillofac Surg; 2015 May; 43(4):537-44. PubMed ID: 25819099
[TBL] [Abstract][Full Text] [Related]
4. Characterizing the immune microenvironment of malignant peripheral nerve sheath tumor by PD-L1 expression and presence of CD8+ tumor infiltrating lymphocytes.
Shurell E; Singh AS; Crompton JG; Jensen S; Li Y; Dry S; Nelson S; Chmielowski B; Bernthal N; Federman N; Tumeh P; Eilber FC
Oncotarget; 2016 Sep; 7(39):64300-64308. PubMed ID: 27588404
[TBL] [Abstract][Full Text] [Related]
5. Recurring intracranial malignant peripheral nerve sheath tumor: case report and systematic review of the literature.
van den Munckhof P; Germans MR; Schouten-van Meeteren AY; Oldenburger F; Troost D; Vandertop WP
Neurosurgery; 2011 Apr; 68(4):E1152-8; discussion E1159. PubMed ID: 21242836
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
[TBL] [Abstract][Full Text] [Related]
7. Intracranial Malignant Peripheral Nerve Sheath Tumors Not Associated with a Cranial Nerve: Systematic Review and Illustrative Case.
Mackel CE; Medeiros I; Moore BE; Zhao Q; Jha R
World Neurosurg; 2021 Dec; 156():76-91. PubMed ID: 34563719
[TBL] [Abstract][Full Text] [Related]
8. Clinical, radiological, and pathological features of 26 intracranial and intraspinal malignant peripheral nerve sheath tumors.
Ren X; Wang J; Hu M; Jiang H; Yang J; Jiang Z
J Neurosurg; 2013 Sep; 119(3):695-708. PubMed ID: 23829815
[TBL] [Abstract][Full Text] [Related]
9. Leptomeningeal metastasis of an intradural malignant peripheral nerve sheath tumor.
Stark AM; Mehdorn HM
J Clin Neurosci; 2013 Aug; 20(8):1181-3. PubMed ID: 23664130
[TBL] [Abstract][Full Text] [Related]
10. Frequency of MED12 mutations in phyllodes tumors: Inverse correlation with histologic grade.
Yoon N; Bae GE; Kang SY; Choi MS; Hwang HW; Kim SW; Lee JE; Nam SJ; Gong G; Lee HJ; Bae YK; Lee A; Cho EY
Genes Chromosomes Cancer; 2016 Jun; 55(6):495-504. PubMed ID: 26856273
[TBL] [Abstract][Full Text] [Related]
11. Malignant peripheral nerve sheath tumors of the spine: results of surgical management from a multicenter study.
Chou D; Bilsky MH; Luzzati A; Fisher CG; Gokaslan ZL; Rhines LD; Dekutoski MB; Fehlings MG; Ghag R; Varga P; Boriani S; Germscheid NM; Reynolds JJ;
J Neurosurg Spine; 2017 Mar; 26(3):291-298. PubMed ID: 27834629
[TBL] [Abstract][Full Text] [Related]
12. A neurogenic tumor containing a low-grade malignant peripheral nerve sheath tumor (MPNST) component with loss of p16 expression and homozygous deletion of CDKN2A/p16: a case report showing progression from a neurofibroma to a high-grade MPNST.
Tajima S; Koda K
Int J Clin Exp Pathol; 2015; 8(5):5113-20. PubMed ID: 26191206
[TBL] [Abstract][Full Text] [Related]
13. Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO).
Valentin T; Le Cesne A; Ray-Coquard I; Italiano A; Decanter G; Bompas E; Isambert N; Thariat J; Linassier C; Bertucci F; Bay JO; Bellesoeur A; Penel N; Le Guellec S; Filleron T; Chevreau C
Eur J Cancer; 2016 Mar; 56():77-84. PubMed ID: 26824706
[TBL] [Abstract][Full Text] [Related]
14. Next-Gen Sequencing Exposes Frequent MED12 Mutations and Actionable Therapeutic Targets in Phyllodes Tumors.
Cani AK; Hovelson DH; McDaniel AS; Sadis S; Haller MJ; Yadati V; Amin AM; Bratley J; Bandla S; Williams PD; Rhodes K; Liu CJ; Quist MJ; Rhodes DR; Grasso CS; Kleer CG; Tomlins SA
Mol Cancer Res; 2015 Apr; 13(4):613-9. PubMed ID: 25593300
[TBL] [Abstract][Full Text] [Related]
15. Comparative Analysis of Head and Neck and Non-Head and Neck Malignant Peripheral Nerve Sheath Tumors.
Patel TD; Shaigany K; Fang CH; Park RC; Baredes S; Eloy JA
Otolaryngol Head Neck Surg; 2016 Jan; 154(1):113-20. PubMed ID: 26408559
[TBL] [Abstract][Full Text] [Related]
16. Schwannoma of the Sinonasal Tract and the Pterygopalatine Fossa with or without Intracranial Extension.
Zhou H; Xing G; Gao X; Wang J; Chen F; Lu L; Zhang Y; Chen Z; Qian X
ORL J Otorhinolaryngol Relat Spec; 2015; 77(2):61-9. PubMed ID: 25791913
[TBL] [Abstract][Full Text] [Related]
17. CTNNB1 (beta-catenin) mutation is rare in brain tumours but involved as a sporadic event in a brain metastasis.
Lee CI; Hsu MY; Chou CH; Wang C; Lo YS; Loh JK; Howng SL; Hong YR
Acta Neurochir (Wien); 2009 Sep; 151(9):1107-11. PubMed ID: 19582367
[TBL] [Abstract][Full Text] [Related]
18. Malignant peripheral nerve sheath tumor of the infratemporal fossa with intracranial extension.
Tamarit M; Navarro R; Alcázar L
Ear Nose Throat J; 2010 Dec; 89(12):596-9. PubMed ID: 21174279
[TBL] [Abstract][Full Text] [Related]
19. Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis.
Crago AM; Chmielecki J; Rosenberg M; O'Connor R; Byrne C; Wilder FG; Thorn K; Agius P; Kuk D; Socci ND; Qin LX; Meyerson M; Hameed M; Singer S
Genes Chromosomes Cancer; 2015 Oct; 54(10):606-15. PubMed ID: 26171757
[TBL] [Abstract][Full Text] [Related]
20. Exomic landscape of MED12 mutation-negative and -positive uterine leiomyomas.
Mäkinen N; Vahteristo P; Bützow R; Sjöberg J; Aaltonen LA
Int J Cancer; 2014 Feb; 134(4):1008-12. PubMed ID: 23913526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
